RNAZ Receives Nasdaq Deficiency Letter, Faces Delisting Due to $1.25M Stockholders' Equity vs $2.5M Requirement
TransCode Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.44
-12% in 1h after detection
Post-detection moves
1h
-12%
1d
-11%
3d
-9.8%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS